Dexa Medica: Indonesia's leading pharma company introduces Werum's PAS-X MES

Lüneburg, Germany / Bangkok, Thailand, 16 June 2020 – As part of their digitization initiative, Dexa Medica started their first full-scope electronic batch recording project with Werum's PAS-X Manufacturing Execution System (MES) at their manufacturing site in Palembang, Indonesia. Dexa Medica is one of Indonesia's largest ethical pharmaceutical companies and a prominent player in the domestic pharmaceutical market.

PAS-X will be integrated with ERP, LIMS, DMS, LDAP and IPC equipment as well as with level 2 automation systems in a phase-wise approach. Dexa Medica uses many latest technologies which received GMP, ISO 9001 and other quality-related certifications. Now, with the start of the MES/EBR project, the Palembang site will be fully digitized. This will enable Dexa Medica to control their manufacturing processes in a flexible and electronic way – based on accurate real-time data – and to achieve major improvements in production quality and efficiency.

"We are very excited and look forward to starting our digital transformation journey and entering a long-term strategic partnership with Werum," states Wimala Widjaja, CIO, Dexa Group. "By implementing Werum's PAS-X MES, we aim to strengthen our ability to generate and capture data from every corner of our quality system and manufacturing processes. And, most importantly, we will lay a strong foundation for Dexa Medica to become a data-driven organization."

In addition to high transparency and increased production performance benefits, PAS-X will help Dexa Medica to meet compliance requirements and accelerate batch release and time to market due to the standardization of manufacturing processes and review by exception. The project will be managed locally by Werum Asia teams from Indonesia and Thailand.